DANAHER CORP. DL-,01/ US2358511028 /
8/30/2024 7:30:21 PM | Chg. -0.75 | Volume | Bid8:04:43 PM | Ask8:04:43 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
240.30EUR | -0.31% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 176.06 bill.EUR | - | - |
GlobeNewswire
8/20
Intelligent Product Solutions Announces that Brad Carlson Joins as VP of Technology and Business Dev...
GlobeNewswire
3/8
Resilinc CEO Honored With a 2024 Pros to Know Lifetime Achievement Award from Supply & Demand Chain ...
GlobeNewswire
2/26
DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Te...
GlobeNewswire
1/29
DANAHER ALERT: Bragar Eagel & Squire, P.C. is Investigating Danaher Corporation on Behalf of Long-Te...
GlobeNewswire
12/13/2023
Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase
GlobeNewswire
11/15/2023
Brady Corporation elects Board of Directors and declares regular dividend to shareholders
GlobeNewswire
11/14/2023
Lincoln Electric Appoints J. Ashley Hall as Senior Vice President, Global Procurement
GlobeNewswire
11/1/2023
Statement from Dr. Jonathan Milner on the suspension of the “Vote AGAINST” campaign
GlobeNewswire
10/16/2023
Jonathan Milner releases presentation to Abcam plc shareholders, outlining reasons to reject Danaher...
GlobeNewswire
10/12/2023
Coave Therapeutics appoints Leading World Experts to newly formed Scientific Advisory Board dedicate...
GlobeNewswire
10/2/2023
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer